Treatment of specific phobia in adults
- PMID: 17112646
- DOI: 10.1016/j.cpr.2006.10.002
Treatment of specific phobia in adults
Abstract
This is a comprehensive review of treatment studies in specific phobia. Acute and long-term efficacy studies of in vivo exposure, virtual reality, cognitive therapy and other treatments from 1960 to 2005 were retrieved from computer search engines. Although specific phobia is a chronic illness and animal extinction studies suggest that relapse is a common phenomenon, little is known about long-term outcome. Treatment gains are generally maintained for one year, but longer follow-up studies are needed to better understand and prevent relapse. Acutely, the treatments are not equally effective among the phobia subtypes. Most phobias respond robustly to in vivo exposure, but it is associated with high dropout rates and low treatment acceptance. Response to systematic desensitization is more moderate. A few studies suggest that virtual reality may be effective in flying and height phobia, but this needs to be substantiated by more controlled trials. Cognitive therapy is most helpful in claustrophobia, and blood-injury phobia is uniquely responsive to applied tension. The limited data on medication have not been promising with the exception of adjunctive D-clycoserine. Despite the acute benefits of in vivo exposure, greater attention should be paid to improve treatment acceptance and retention, and additional controlled studies of more acceptable treatments are needed.
Similar articles
-
Social phobia. Longitudinal course and long-term outcome of cognitive-behavioral treatment.Psychiatr Clin North Am. 1995 Dec;18(4):821-42. Psychiatr Clin North Am. 1995. PMID: 8748383 Review.
-
[Treating specific childhood phobia in a single session? A systematic review of the literature].Encephale. 2013 Apr;39(2):109-14. doi: 10.1016/j.encep.2012.04.002. Epub 2012 Jun 14. Encephale. 2013. PMID: 23095586 Review. French.
-
Specific phobias.Psychiatr Clin North Am. 2009 Sep;32(3):577-91. doi: 10.1016/j.psc.2009.05.008. Psychiatr Clin North Am. 2009. PMID: 19716991 Review.
-
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.Arch Gen Psychiatry. 2004 Nov;61(11):1136-44. doi: 10.1001/archpsyc.61.11.1136. Arch Gen Psychiatry. 2004. PMID: 15520361 Clinical Trial.
-
Preliminary research on the efficacy of virtual reality exposure therapy to treat driving phobia.Cyberpsychol Behav. 2003 Oct;6(5):459-65. doi: 10.1089/109493103769710488. Cyberpsychol Behav. 2003. PMID: 14583121 Clinical Trial.
Cited by
-
The Effect of Augmented Reality and Virtual Reality on Inducing Anxiety for Exposure Therapy: A Comparison Using Heart Rate Variability.J Healthc Eng. 2018 Nov 25;2018:6357351. doi: 10.1155/2018/6357351. eCollection 2018. J Healthc Eng. 2018. PMID: 30595830 Free PMC article.
-
Specific phobias.Lancet Psychiatry. 2018 Aug;5(8):678-686. doi: 10.1016/S2215-0366(18)30169-X. Lancet Psychiatry. 2018. PMID: 30060873 Free PMC article. Review.
-
Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.Int J Neuropsychopharmacol. 2016 Jun 1;19(6):pyv128. doi: 10.1093/ijnp/pyv128. Print 2016 Jun. Int J Neuropsychopharmacol. 2016. PMID: 26625894 Free PMC article.
-
Cognitive Biases in Blood-Injection-Injury Phobia: A Review.Front Psychiatry. 2021 Jul 13;12:678891. doi: 10.3389/fpsyt.2021.678891. eCollection 2021. Front Psychiatry. 2021. PMID: 34326784 Free PMC article. Review.
-
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.BMC Psychiatry. 2014;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. BMC Psychiatry. 2014. PMID: 25081580 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical